Lotus Pharmaceutical Co Ltd (1795) — Cash Flow Reinvestment Rate
Lotus Pharmaceutical Co Ltd (1795) has a Cash Flow Reinvestment Rate of 1.19x as of December 2025, reinvesting NT$1.60 Billion (capex NT$1.60 Billion ) from operating cash flow of NT$1.35 Billion. Check 1795 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Lotus Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Lotus Pharmaceutical Co Ltd across 13 annual periods. Explore investment intensity of Lotus Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Lotus Pharmaceutical Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Lotus Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Lotus Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | NT$4.35 Billion | NT$7.48 Billion | NT$4.35 Billion | ▲ +144.4% |
| 2024 | 0.24x | NT$1.47 Billion | NT$6.15 Billion | NT$1.47 Billion | ▼ -94.1% |
| 2023 | 4.04x | NT$6.52 Billion | NT$1.61 Billion | NT$3.28 Billion | ▲ +596.0% |
| 2022 | 0.58x | NT$2.16 Billion | NT$3.72 Billion | NT$577.16 Million | ▼ -97.8% |
| 2021 | 26.73x | NT$3.20 Billion | NT$119.66 Million | NT$1.62 Billion | ▲ +2491.9% |
| 2020 | 1.03x | NT$2.01 Billion | NT$1.95 Billion | NT$2.00 Billion | ▼ -81.8% |
| 2019 | 5.68x | NT$1.72 Billion | NT$302.81 Million | NT$1.10 Billion | ▲ +345.6% |
| 2018 | 1.27x | NT$1.02 Billion | NT$796.98 Million | NT$399.07 Million | ▼ -19.7% |
| 2017 | 1.59x | NT$940.19 Million | NT$592.29 Million | NT$914.84 Million | ▲ +58.1% |
| 2016 | 1.00x | NT$1.24 Billion | NT$1.23 Billion | NT$660.48 Million | ▲ +107.7% |
| 2015 | 0.48x | NT$520.71 Million | NT$1.08 Billion | NT$520.71 Million | ▼ -80.6% |
| 2010 | 2.49x | NT$147.57 Million | NT$59.19 Million | NT$147.57 Million | ▲ +786.5% |
| 2009 | 0.28x | NT$25.17 Million | NT$89.50 Million | NT$25.17 Million | — |